Breast Cancer News

In an attempt to give back, a local jewelry store said it has planted more than $1,000 shiny gold boxes filled with jewelry from Stevens Point all the way up to the Upper Peninsula of Michigan.

Cell Therapeutics, Inc. announced today that the European Medicines Agency has granted pixantrone orphan drug designation for the treatment of DLBCL which accounts for about 80% of aggressive non-Hodgkin's lymphoma.

An Avon-based company that advises dozens of health insurers nationwide says the real problem with mammograms is radiologists who aren't reading them correctly.

Labour promised that women with signs of breast cancer would see a specialist within two weeks by 2008 Women are still waiting months to find out whether they have breast cancer, the Government figure in charge of tackling the disease admitted last night.

Main Category: Breast Cancer Also Included In: Cancer / Oncology Article Date: 14 Dec 2009 - 3:00 PST Breast cancer survivors and advocates from all seven California Affiliates of Susan G. Komen for the Cure signaled their alarm at the recently announced cuts to California's Every Woman Counts program, which would effectively shut the doors to ...

There are many issues that face men whose wives have breast cancer. IS your wife a breast cancer survivor? Has she had a mastectomy? I have interviewed many women with breast cancer, as well as their spouses.

Main Category: Breast Cancer Also Included In: Medical Devices / Diagnostics ; Regulatory Affairs / Drug Approvals Article Date: 18 Dec 2009 - 0:00 PST Agendia, a world leader in molecular cancer diagnostics, announced that the US Food and Drug Administration cleared its MammaPrint breast cancer recurrence test for all ages.

Abstract Background Breast cancers contain a minority population of cancer cells characterized by CD44 expression but low or undetectable levels of CD24 that have higher tumorigenic capacity than other subtypes of cancer cells.

Melody had never heard of mucinous breast cancer when she received her diagnosis.

The federal government's Agency for Healthcare Research and Quality, apparently undaunted by the controversy it kicked up last month over mammograms, has waded back into the breast cancer thicket with advice on how best to distinguish benign breast lumps from possible malignancies.

Dec 12, 2009 - Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients.

Angels represent many things to different people. For some they are a sign of guidance, as in our guardian angel.

SAN DIEGO, Dec. 12 /PRNewswire/ -- bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from three studies using the company's breast cancer molecular test.

Genentech, Inc., a wholly owned member of the Roche Group , today announced positive results from a Phase II study of trastuzumab-DM1 . As assessed by independent review, T-DM1 shrank the tumors in 33 percent of women with advanced HER2-positive breast cancer that had worsened following previous treatment.

A new study finds a significant racial disparity in breast cancer treatment: Black women are less likely than their white counterparts to receive radiation therapy after a lumpectomy.

By Laura Farmer Sherman Executive Director, Susan G. Komen for the Cure San Diego Breast cancer survivors and advocates from all seven California Affiliates of Susan G. Komen for the Cure signaled their alarm this week at the recently announced cuts to California's Every Woman Counts program, which would effectively shut the doors to breast cancer ...

Liberals are so incensed at Connecticut Senator Joe Liberman's refusal to vote for ObamaCare, that they have taken to attacking his wife, who works for a prominent breast cancer organization.

Main Category: Breast Cancer Also Included In: Cardiovascular / Cardiology ; Women's Health / Gynecology ; Bones / Orthopaedics Article Date: 16 Dec 2009 - 3:00 PST The following summarizes findings reported last week at the San Antonio Breast Cancer Symposium .

A LEADING breast cancer charity has called on Boots the chemist to stop stocking a product which claims to help women to detect abnormalities in their breasts.

Pfizer Inc. today announced results from studies evaluating neratinib , an investigational, orally administered, pan-ErbB inhibitor, in patients with human epidermal growth factor receptor-2 positive breast cancer at the 2009 CTRC-AACR San Antonio Breast Cancer Symposium .